By Sydney Halleman | July 21, 2026
In a significant maneuver to solidify its footprint in the rapidly expanding home-based healthcare sector, Cardinal Health announced on Monday a definitive agreement to acquire two key assets: the diabetes supply business of AdaptHealth and the independent medical supplier Strive Medical. The move is the latest in a series of aggressive investments by the healthcare giant, aimed at capturing the rising demand for direct-to-patient medical distribution.
The transaction, which values the combined assets at approximately $235 million, underscores Cardinal Health’s long-term strategy to pivot toward the "hospital-at-home" model. By integrating these businesses into its existing at-home solutions portfolio, Cardinal is positioning itself to be the primary provider for patients managing chronic conditions from the comfort of their own residences.
Main Facts: The Scope of the Transaction
The deal involves the acquisition of AdaptHealth’s diabetes supply division—which serves over 225,000 patients annually—and Strive Medical, a specialty supplier with a focus on urology, wound care, ostomy, and incontinence supplies that serves approximately 20,000 customers per year.
Market analysts estimate that of the $235 million total deal value, approximately $125 million is attributed to the purchase of Strive Medical, with the remainder dedicated to the AdaptHealth diabetes business. While Cardinal Health has not disclosed a specific closing date for the acquisitions, the announcement serves as a clear signal of intent to scale its "other" business segment, which includes the company’s logistics and home-delivery capabilities.
These acquisitions are designed to complement Cardinal’s existing infrastructure. By absorbing AdaptHealth’s established customer base and Strive’s specialized product expertise, Cardinal is creating a more comprehensive "one-stop shop" for patients requiring recurring medical supplies.
Chronology: A Pattern of Strategic Growth
Cardinal Health’s recent activity follows a deliberate trajectory of expansion that has been unfolding over the past several years. The company, founded in 1979 and historically known for its vast pharmaceutical distribution network, has been aggressively diversifying its revenue streams.
- Early 2025: Cardinal initiates a broader strategic review of its "at-home" segment, identifying it as a primary growth driver.
- April 2025: Cardinal closes the $1.1 billion acquisition of Advanced Diabetes Supply (ADS). This deal was a watershed moment, onboarding nearly 500,000 new patients and signaling to the market that Cardinal intended to lead the direct-to-patient diabetes market.
- August 2025: Continuing its diversification into specialty care, Cardinal acquires Solaris Health, a leading urology multi-specialty organization, further strengthening its clinical footprint.
- July 2026: The current announcement confirms the purchase of the AdaptHealth diabetes unit and Strive Medical, building directly upon the integration successes of the ADS deal.
Executives noted that the integration of ADS has been faster than anticipated, providing the operational confidence required to pursue these latest acquisitions.
Supporting Data: The Financial Boon of Home Care
The shift toward home-based care is not merely a clinical trend; it is a financial powerhouse for Cardinal Health. According to the company’s most recent fiscal filings, the at-home solutions unit has emerged as a high-performing engine for growth.
In the third quarter of 2026, the at-home solutions division contributed a staggering $1.7 billion in revenue. This performance helped drive a 34% year-over-year profit increase for the company’s "other" business segment. The success of this division has been so consistent that Cardinal Health was prompted to revise its fiscal year profit guidance upward for the segment ending June 30.
The business model relies on a high-volume, recurring revenue stream. As patients with diabetes, chronic wounds, or urological needs require monthly deliveries of supplies—such as continuous glucose monitors (CGMs) and ostomy bags—Cardinal is able to leverage its supply chain logistics to maintain stable, predictable growth. This model effectively insulates the company from some of the volatility found in traditional pharmaceutical sales.
Official Responses and Strategic Rationale
In the aftermath of the announcement, Cardinal Health executives emphasized that these acquisitions are not just about adding volume, but about enhancing the patient experience. The goal is to create a seamless interface where patients can receive all necessary supplies through a single, reliable provider.
"Our commitment to the at-home care space remains a core pillar of our long-term strategy," a company representative stated. "By integrating specialized suppliers like Strive and expanding our diabetes reach through the AdaptHealth deal, we are ensuring that we can meet the patient exactly where they are—in their homes."
AdaptHealth, for its part, framed the divestiture as a strategic realignment. By offloading its diabetes supply business, AdaptHealth is likely looking to focus its capital and resources on other segments of its healthcare service portfolio. The transaction allows AdaptHealth to capitalize on the high value of its diabetes unit while Cardinal Health assumes the logistics and management responsibilities for the massive patient population.
Implications: The Future of the "At-Home" Market
The implications of this deal are far-reaching for the healthcare supply industry. Several key trends are highlighted by this consolidation:
1. The Consolidation of Care
As major players like Cardinal Health acquire smaller, specialized entities, the market is becoming increasingly consolidated. This creates a barrier to entry for smaller, independent medical suppliers and places more power in the hands of distributors with the logistics infrastructure to handle "last-mile" delivery.
2. The Rise of the "Hospital-at-Home"
The industry is moving toward a future where chronic disease management is performed outside of clinical settings. This reduces the burden on hospitals, lowers the overall cost of care, and provides patients with greater autonomy. Cardinal’s move is a clear bet that this model will remain the dominant preference for both payors and patients for the foreseeable future.
3. Integration as a Competitive Advantage
The rapid integration of Advanced Diabetes Supply (ADS) proved that Cardinal’s platform could absorb large acquisitions without disrupting service. This capability will be tested again as the company integrates the AdaptHealth and Strive businesses. If successful, Cardinal will solidify its position as the undisputed leader in the direct-to-patient medical supply market.
4. Impact on Patient Outcomes
While the business implications are clear, the impact on patients remains the ultimate metric of success. With more streamlined access to supplies, patients may see improved adherence to treatment protocols. For individuals managing diabetes or other chronic conditions, the reliability of a large, technologically advanced distributor can mean the difference between a successful treatment regimen and a hospitalization.
Conclusion
The acquisition of AdaptHealth’s diabetes business and Strive Medical represents a pivotal moment in Cardinal Health’s transformation. By moving deeper into the home-care segment, the company is aligning itself with the future of American healthcare delivery.
As the lines between home, clinic, and pharmacy continue to blur, Cardinal Health’s strategy to control the supply chain—from the manufacturer to the patient’s front door—appears not only prudent but essential for growth in a changing economic landscape. Investors and industry observers alike will be watching closely to see how the company navigates the integration of these new assets and whether the promised synergies translate into continued, long-term profitability.
